Showing results (141-150 of 226) with videos related to
Sort By:
Pageof 23
Surgical Infections|October 6, 2005
Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomized, double-blind comparative studyTimothy C Fabian, Thomas M File, John M Embil, et al.The Journal of Infectious Diseases|October 5, 2013
Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumoniaRobert L Sherwin, Sharon Gray, Ronika Alexander, et al.Diagnostic Microbiology and Infectious Disease|November 7, 2017
The effect of pulmonary surfactant on the in vitro activity of Iclaprim against common respiratory bacterial pathogensDavid B Huang, Leonard R Duncan, Robert K Flamm, et al.Antimicrobial Agents and Chemotherapy|June 25, 2004
Effects of fluoroquinolones on the migration of human phagocytes through Chlamydia pneumoniae-infected and tumor necrosis factor alpha-stimulated endothelial cellsSilvia M Uriarte, Robert E Molestina, Richard D Miller, et al.The Journal of Infectious Diseases|May 23, 2002
Effect of macrolide antibiotics on human endothelial cells activated by Chlamydia pneumoniae infection and tumor necrosis factor-alphaSilvia M Uriarte, Robert E Molestina, Richard D Miller, et al.Journal of Critical Care|November 26, 2010
Ventilator-associated pneumonia in critically ill stroke patients: frequency, risk factors, and outcomesYusuke Kasuya, James L Hargett, Rainer Lenhardt, et al.American Journal of Infection Control|March 4, 2014
The value of ready-to-use disinfectant wipes: compliance, employee time, and costsTimothy L Wiemken, Daniel R Curran, Emily B Pacholski, et al.American Journal of Infection Control|April 30, 2014
A single genotype of Acinetobacter baumannii expresses multiple antibiotic susceptibility phenotypesTimothy L Wiemken, Daniel Curran, Robert R Kelley, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 12, 2010
Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumoniaThomas M File, Donald E Low, Paul B Eckburg, et al.The American Journal of Medicine|July 5, 2005
A clinician's guide to the appropriate and accurate use of antibiotics: the Council for Appropriate and Rational Antibiotic Therapy (CARAT) criteriaThomas G Slama, Alpesh Amin, Stephen A Brunton, et al.Pageof 23